Jack Wallace
Stock Analyst at Guggenheim
(2.86)
# 1,647
Out of 4,789 analysts
22
Total ratings
52.63%
Success rate
7.01%
Average return
Main Sectors:
Stocks Rated by Jack Wallace
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Buy | $233 → $249 | $227.90 | +9.26% | 4 | Oct 1, 2024 | |
| WW WW International | Maintains: Buy | $12 → $6 | $0.55 | +997.49% | 3 | Aug 2, 2024 | |
| HIMS Hims & Hers Health | Maintains: Buy | $15 → $17 | $31.05 | -45.25% | 4 | Feb 27, 2024 | |
| HCAT Health Catalyst | Upgrades: Buy | $14 | $4.33 | +223.33% | 3 | Jan 26, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $253 → $220 | $171.24 | +28.47% | 1 | Nov 3, 2023 | |
| PHR Phreesia | Maintains: Buy | $35 → $40 | $25.46 | +57.11% | 5 | Mar 29, 2023 | |
| AMWL American Well | Reiterates: Buy | $100 | $7.17 | +1,294.70% | 1 | Mar 15, 2023 | |
| PINC Premier | Initiates: Neutral | n/a | $19.48 | - | 1 | Apr 14, 2022 |
Veeva Systems
Oct 1, 2024
Maintains: Buy
Price Target: $233 → $249
Current: $227.90
Upside: +9.26%
WW International
Aug 2, 2024
Maintains: Buy
Price Target: $12 → $6
Current: $0.55
Upside: +997.49%
Hims & Hers Health
Feb 27, 2024
Maintains: Buy
Price Target: $15 → $17
Current: $31.05
Upside: -45.25%
Health Catalyst
Jan 26, 2024
Upgrades: Buy
Price Target: $14
Current: $4.33
Upside: +223.33%
IQVIA Holdings
Nov 3, 2023
Maintains: Buy
Price Target: $253 → $220
Current: $171.24
Upside: +28.47%
Phreesia
Mar 29, 2023
Maintains: Buy
Price Target: $35 → $40
Current: $25.46
Upside: +57.11%
American Well
Mar 15, 2023
Reiterates: Buy
Price Target: $100
Current: $7.17
Upside: +1,294.70%
Premier
Apr 14, 2022
Initiates: Neutral
Price Target: n/a
Current: $19.48
Upside: -